Advances in 16S rRNA ‐Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis
Microbial Biotechnology · 2025-02 · 18 (2)
DOI: 10.1111/1751-7915.70115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 24.02.2025. Verfasst von Yingying Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: RNA, Ribosomal, 16S, Biomarkers, Tumor, Stomach Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Plan of Shenyang Bureau of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gastric cancer (GC) is a malignant tumour with high morbidity and mortality worldwide, and there is an urgent need for early diagnosis and precision treatment. In recent years, the role of microbiota in the occurrence and development of GC has drawn extensive attention. Particularly, the in‐depth study of GC‐related microbiota by 16S rRNA sequencing technology has offered valuable tools and new perspectives for exploring the microbial characteristics of GC patients. This review systematically summarises the microbial diversity and composition of GC and non‐GC samples based on 16S rRNA data, outlines the progress in identifying GC‐related microbial biomarkers, explores the potential mechanisms by which diagnostic microbial biomarkers influence the development of GC, and reflects on the limitations of present studies. By integrating the current evidence, this review intends to offer a new theoretical foundation and further direction for the clinical translation of microbiota research in the diagnosis and treatment of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, China.
- Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, China.
- Key Laboratory of GI Cancer Etiology and Prevention in Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
ORCID-Profile: Yuehua Gong
Förderung
- the National Natural Science Foundation of China
- the Plan of Shenyang Bureau of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Qiu, X., Chu, A., Chen, J., Wang, L., Sun, X., Wang, B., Yuan, Y., & Gong, Y. (2025). Advances in 16S rRNA ‐Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis. Microbial Biotechnology, 18(2). https://doi.org/10.1111/1751-7915.70115
Vancouver
Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, et al. Advances in 16S rRNA ‐Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis. Microbial Biotechnology. 2025;18(2). doi:10.1111/1751-7915.70115
BibTeX
@article{Wang2025,
author = {Wang, Yingying and Qiu, Xunan and Chu, Aining and Chen, Jijun and Wang, Lu and Sun, Xiaohu and Wang, Bengang and Yuan, Yuan and Gong, Yuehua},
title = {Advances in 16S rRNA ‐Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis},
journal = {Microbial Biotechnology},
year = {2025},
volume = {18},
number = {2},
doi = {10.1111/1751-7915.70115}
}
EUVIMED